{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T04:34:21Z","timestamp":1774499661505,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s13318-021-00708-x","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T08:03:21Z","timestamp":1628496201000},"page":"677-684","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gentamicin Dosing in Neonates with Normal Renal Function: Trough and Peak Levels"],"prefix":"10.1007","volume":"46","author":[{"given":"Kristin","family":"O\u2019Connor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2179-4367","authenticated-orcid":false,"given":"Mark W.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Koorts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Cartwright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Whitfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"key":"708_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11096-008-9255-y","volume":"31","author":"I Hagen","year":"2009","unstructured":"Hagen I, Oymar K. Pharmacological differences between once daily and twice daily gentamicin dosage in newborns with suspected sepsis. Pharm World Sci. 2009;31:18\u201323.","journal-title":"Pharm World Sci"},{"key":"708_CR2","first-page":"119","volume":"20","author":"YS Low","year":"2015","unstructured":"Low YS, Tan SL, Wan AS. Extended-interval gentamicin dosing in achieving therapeutic concentrations in Malaysian Neonates. J Pediatr Pharmacol Ther. 2015;20:119\u201325.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"708_CR3","first-page":"264","volume":"15","author":"AE Hitron","year":"2010","unstructured":"Hitron AE, Yao S, Scarpace SB. Accuracy of empiric gentamicin dosing guidelines in neonates. J Pediatr Pharmacol Ther. 2010;15:264\u201373.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"708_CR4","first-page":"92","volume":"4","author":"R Lannigian","year":"2001","unstructured":"Lannigian R, Thomson A. Evaluation of 22 neonatal gentamicin dosage protocols using Bayesian approach. Paediatr Perinat Drug Ther. 2001;4:92\u2013100.","journal-title":"Paediatr Perinat Drug Ther."},{"key":"708_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/adc.67.1_Spec_No.57","volume":"67","author":"H Skopnik","year":"1992","unstructured":"Skopnik H, Wallraf R, Nies B, Troster K, Heimann G. Pharmacokinetics and antibacterial activity of daily gentamicin. Arch Dis Childhood. 1992;67:57\u201361.","journal-title":"Arch Dis Childhood."},{"key":"708_CR6","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1093\/jac\/dkr351","volume":"66","author":"S Kadambari","year":"2011","unstructured":"Kadambari S, Heath PT, Sharland M, Lewis S, Nichols A, Turner MA. Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units. J Antimicrob Chemother. 2011;66:2647\u201350.","journal-title":"J Antimicrob Chemother"},{"key":"708_CR7","first-page":"634","volume":"17","author":"MW Davies","year":"2000","unstructured":"Davies MW. Gentamicin dosage in neonates. Infect Med. 2000;17:634.","journal-title":"Infect Med."},{"key":"708_CR8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1046\/j.1440-1754.1999.00391.x","volume":"35","author":"MW Davies","year":"1999","unstructured":"Davies MW, Cartwright DW. Gentamicin dosage intervals. J Paediatr Child Health. 1999;35:412.","journal-title":"J Paediatr Child Health"},{"key":"708_CR9","first-page":"CD005091","volume":"25","author":"SC Rao","year":"2006","unstructured":"Rao SC, Ahmed M, Hagan R. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Cochrane Database Syst Rev. 2006;25:CD005091.","journal-title":"Cochrane Database Syst Rev"},{"key":"708_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2146\/ajhp100114","volume":"68","author":"F Fullas","year":"2011","unstructured":"Fullas F, Padomek MT, Thieman CJ, Van Gorp AE. Comparative evaluation of six extended-interval gentamicin dosing regimens in preterm and full-term neonates. Am J Health-Syst Pharm. 2011;68:52\u20136.","journal-title":"Am J Health-Syst Pharm."},{"key":"708_CR11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/ajhp\/56.5.440","volume":"56","author":"TM Langlass","year":"1999","unstructured":"Langlass TM, Mickle TR. Standard gentamicin dosage regimen in neonates. Am J Health-Syst Pharm. 1999;56:440\u20133.","journal-title":"Am J Health-Syst Pharm."},{"key":"708_CR12","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1093\/ajhp\/55.21.2280","volume":"55","author":"JE Murphy","year":"1998","unstructured":"Murphy JE, Austin ML, Frye RF. Evaluation of gentamicin pharmacokinetics and dosing protocols in 195 neonates. Am J Health-Syst Pharm. 1998;55:2280\u20138.","journal-title":"Am J Health-Syst Pharm."},{"key":"708_CR13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1592\/phco.23.5.585.32196","volume":"23","author":"R DiCenzo","year":"2003","unstructured":"DiCenzo R, Forrest A, Slish JC, et al. A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates. Pharmcotherapy. 2003;23:585\u201391.","journal-title":"Pharmcotherapy."},{"key":"708_CR14","first-page":"55","volume-title":"Clinical pharmacokinetics handbook","author":"LA Bauer","year":"2005","unstructured":"Bauer LA. Aminoglycoside antibiotics. In: Bauer LA, editor. Clinical pharmacokinetics handbook. New York: The McGraw-Hill Companies; 2005. p. 55\u20137."},{"key":"708_CR15","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/sj.jp.7210996","volume":"23","author":"A Hansen","year":"2003","unstructured":"Hansen A, Forbes P, Arnold A, O\u2019Rouke E. Once-daily gentamicin dosing for the preterm and term newborn: Proposal for a simple regimen that achieves target levels. J Perinat Med. 2003;23:635\u20139.","journal-title":"J Perinat Med"},{"key":"708_CR16","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1592\/phco.29.11.1297","volume":"29","author":"DS Hoff","year":"2009","unstructured":"Hoff DS, Wilcox RA, Tollefson LM, Lipnik PG, Commers AR, Liu M. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates. Pharmacotherapy. 2009;29:1297\u2013305.","journal-title":"Pharmacotherapy"},{"issue":"2","key":"708_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2165\/00003088-200948020-00001","volume":"48","author":"DJ Touw","year":"2009","unstructured":"Touw DJ, Westerman EM, Sprij AJ. Therapeutic drug monitoring of aminoglycosides in neonates. Clin Pharmacokinet. 2009;48(2):71\u201388.","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"708_CR18","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1111\/tmi.12608","volume":"20","author":"GM Musiime","year":"2015","unstructured":"Musiime GM, Seale AC, Moxon SG, Lawn JE. Risk of gentamicin toxicity in neonates treated for possible severe bacterial infection in low- and middle-income countries: systematic review. Trop Med Int Health. 2015;20(12):1593\u2013606.","journal-title":"Trop Med Int Health"},{"issue":"3","key":"708_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1586\/14787210.2014.878648","volume":"12","author":"A Kent","year":"2014","unstructured":"Kent A, Turner MA, Sharland M, Heath PT. Aminoglycoside toxicity in neonates: something to worry about? Expert Rev Anti Infect Ther. 2014;12(3):319\u201331.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"708_CR20","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1046\/j.1440-1754.1998.00306.x","volume":"34","author":"MW Davies","year":"1998","unstructured":"Davies MW, Cartwright DW. Gentamicin dosage intervals in neonates: longer dosage interval\u2014less toxicity. J Paediatr Child Health. 1998;34:577\u201380.","journal-title":"J Paediatr Child Health"},{"key":"708_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1136\/adc.57.2.123","volume":"57","author":"H Feldman","year":"1982","unstructured":"Feldman H, Guignard J-P. Plasma creatinine in the first month of life. Arch Dis Child. 1982;57:123\u20136.","journal-title":"Arch Dis Child"},{"key":"708_CR22","doi-asserted-by":"publisher","unstructured":"Ahmed TA. Pharmacokinetics of drugs following IV bolus, IV infusion, and oral administration [Internet]. Intechopen; 2015 [cited 2019 Jul 9]. https:\/\/www.intechopen.com\/books\/basic-pharmacokinetic-concepts-and-some-clinical-applications\/pharmacokinetics-of-drugs-following-iv-bolus-iv-infusion-and-oral-administration, https:\/\/doi.org\/10.5772\/61573","DOI":"10.5772\/61573"},{"key":"708_CR23","unstructured":"Beckman Coulter Inc. Chemistry Information Sheet 0151Gentamicin. https:\/\/www.beckmancoulter.com\/wsrportal\/techdocs?docname=\/cis\/A18492\/%25%25\/EN_GEN.pdf. Accessed 6 July 2021."},{"key":"708_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/infdis\/155.1.93","volume":"155","author":"RD Moore","year":"1987","unstructured":"Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis. 1987;155:93\u20139.","journal-title":"J Infect Dis"},{"key":"708_CR25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/adc.2004.056317","volume":"90","author":"E Nestaas","year":"2005","unstructured":"Nestaas E, Bangstad HJ, Sandvik L, Wathe KO. Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2005;90:294\u2013300.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"708_CR26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2165\/00003495-200161060-00001","volume":"61","author":"ML Barclay","year":"2001","unstructured":"Barclay ML, Begg EJ. Aminoglycoside adaptive resistance: importance for effective dosage regimens. Drugs. 2001;61:713\u201321.","journal-title":"Drugs"},{"key":"708_CR27","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/clinchem\/43.1.222","volume":"43","author":"G Koren","year":"1997","unstructured":"Koren G. Therapeutic drug monitoring principles in the neonate. Clin Chem. 1997;43:222\u20137.","journal-title":"Clin Chem"},{"key":"708_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1023\/A:1012221801816","volume":"23","author":"N Gooding","year":"2001","unstructured":"Gooding N, Elias-Jones A, Shenoy M. Gentamicin dosing in neonatal patients. Pharm World Sci. 2001;23:179\u201380.","journal-title":"Pharm World Sci"},{"issue":"2","key":"708_CR29","first-page":"119","volume":"20","author":"YS Low","year":"2015","unstructured":"Low YS, Tan SL, Wan ASL. Extended-interval gentamicin dosing in achieving therapeutic concentrations in Malaysian neonates. J Pediatric Pharmacol Ther. 2015;20(2):119\u201327.","journal-title":"J Pediatric Pharmacol Ther."},{"issue":"2","key":"708_CR30","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/jac\/dkl244","volume":"58","author":"B Garc\u00eda","year":"2006","unstructured":"Garc\u00eda B, Barcia E, P\u00e9rez F, Molina IT. Population pharmacokinetics of gentamicin in preterm newborns. J Antimicrob Chemother. 2006;58(2):372\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"708_CR31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/00007691-200208000-00011","volume":"24","author":"LML Stolk","year":"2002","unstructured":"Stolk LML, Degraeuwe PLJ, Nieman FHM, De Wolf MC, Boer AD. Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates. Ther Drug Monit. 2002;24:527\u201331.","journal-title":"Ther Drug Monit"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-021-00708-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-021-00708-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-021-00708-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T08:27:26Z","timestamp":1630052846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-021-00708-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["708"],"URL":"https:\/\/doi.org\/10.1007\/s13318-021-00708-x","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"assertion":[{"value":"26 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No source of funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"No conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study received ethical approval from the Royal Brisbane and Women\u2019s Hospital Human Research Ethics Committee (reference no. HREC\/13\/QRBW\/12), and all procedures in this study were in accordance with the 1964 Helsinki Declaration (and its amendments).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The parent or carer of each infant gave written informed consent for their infant to participate in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"MD, KW and DC contributed to the conception and design of this study; KOC and KW performed the statistical analysis and drafted the manuscript; PK, MD and DC critically reviewed the manuscript; MD and KW supervised the whole study process. All authors read and approved the final manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}